SCHEMBL21017583

SCHEMBL21017583

CN(C)CCCCCCOc1ccc2[nH]c(-c3ccc(-c4nc5ccc(OCCCCCCN(C)C)cc5[nH]4)cc3)nc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 7/20 0.64
▸ CHEK2 O96017 2/20 0.61
▸ PLG P00747 3/20 0.53
▸ PLAU P00749 3/20 0.53
▸ NPC1 O15118 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ TP53 P04637 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ HDAC3 O15379 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21018057 0.95 ACHE (0.69) ACHECHEK2PLGPLAUNPC1
SCHEMBL23153377 0.95 ACHE (0.69) ACHECHEK2PLGPLAUNPC1
SCHEMBL20982566 0.94 ACHE (0.70) ACHECHEK2PLGPLAUNPC1
SCHEMBL20982619 0.91 CHEK2 (0.72) ACHECHEK2PLGPLAUNPC1
SCHEMBL21017655 0.91 ACHE (0.65) ACHECHEK2NPC1ALDH1A1LMNA
SCHEMBL21017614 0.90 ACHE (0.65) ACHECHEK2PLGPLAUALDH1A1
SCHEMBL21018380 0.89 CHEK2 (0.71) ACHECHEK2PLGPLAUNPC1
SCHEMBL21017802 0.89 CHEK2 (0.62) ACHECHEK2PLGPLAUNPC1
SCHEMBL23153375 0.89 CHEK2 (0.62) ACHECHEK2PLGPLAUNPC1
SCHEMBL21017228 0.88 ACHE (0.66) ACHECHEK2PLGPLAUALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190152924-A1 BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING THE SAME UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152924-A1 BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING THE SAME HNRNPH1, HNRNPH3, HNRNPUL2 ACHE 2382/4885CHEK2 1163/4885PLG 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback